誉衡药业：第十一批集采涉及与公司有关的主要产品为普伐他汀钠片，该产品未在集采中中选

Group 1 - The core point of the article is that Yuheng Pharmaceutical (002437.SZ) participated in the 11th batch of centralized procurement, but its main product, Pravastatin Sodium Tablets, developed in collaboration with Daiichi Sankyo, was not selected in the procurement process [2] Group 2 - The company responded to an investor inquiry on an interactive platform regarding its participation in the 11th batch of centralized procurement [2] - The specific product mentioned, Pravastatin Sodium Tablets, is significant to the company's portfolio but did not achieve selection in this round of procurement [2]